BioHarvest Sciences Inc
Company Profile
Business description
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Contact
1140-625 Howe Street
VancouverBCV6C 2T6
CANT: +1 604 689-5722
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2026
Employees
89
Stocks News & Analysis
stocks
The best AI stocks to buy now
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,852.70 | 29.50 | 0.33% |
| CAC 40 | 7,729.69 | 39.52 | -0.51% |
| DAX 40 | 24,806.97 | 297.39 | -1.18% |
| Dow JONES (US) | 51,231.64 | 51.77 | 0.10% |
| FTSE 100 | 10,441.60 | 16.90 | -0.16% |
| HKSE | 23,785.79 | 344.71 | -1.43% |
| NASDAQ | 27,193.34 | 345.35 | -1.25% |
| Nikkei 225 | 68,619.11 | 423.00 | -0.61% |
| NZX 50 Index | 13,667.17 | 24.68 | -0.18% |
| S&P 500 | 7,765.36 | 36.41 | -0.47% |
| S&P/ASX 200 | 8,695.90 | 35.00 | 0.40% |
| SSE Composite Index | 3,811.90 | 30.29 | -0.79% |